Traditional Chinese medicine composition for treating broiler ascites syndrome
By screening out traditional Chinese medicine compositions of Poria, Tangerine peel, Scutellaria baicalensis, Astragalus, Cecilia, Ginger, Mercury, and Maurozi, combined with data mining and online pharmacology technology, the treatment problem of ascites syndrome in broiler was solved, and the problem of achieving the realization of Safe and effective treatment effects have enhanced the value of Tibetan medicine in the treatment of poultry and livestock diseases.
Patent Information
- Application Number
- CN202410790489.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-19
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-06-19
AI Technical Summary
Ascites syndrome in broiler is a disease that causes high mortality and economic losses in broiler chickens. The existing technology has not yet effectively used Tibetan medicines such as broccoli and mahogany for treatment.
By screening out traditional Chinese medicine compositions of Poria, Tangerine peel, Scutellaria baicalensis, Astragalus, Cephala, Ginger, Mercury and Mahose, combined with data mining and online pharmacology technology, an effective Tibetan medicine saffron prescription was obtained. , used to treat ascites syndrome in broiler chickens.
This traditional Chinese medicine composition significantly reduces the ascites heart index of broilers, reduces inflammatory cell infiltration and oxidative stress in the lungs, provides a safe and effective treatment plan, and further explores the medicinal value of Tibetan medicine in the treatment of poultry and livestock diseases.
Smart Images

Figure CN118924866A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of animal medicine, and in particular to a traditional Chinese medicine composition for treating broiler ascites syndrome. Background Art
[0002] Broiler Ascites Syndrome (BAS), also known as broiler pulmonary hypertension syndrome, is a non-infectious mass disease in which broilers develop pulmonary hypertension in a relatively hypoxic state, accompanied by varying degrees of pathological changes in parenchymal organs such as the heart, liver, lungs and kidneys. The disease is a nutritional metabolic disease caused by the combined effects of multiple pathogens and occurs in fast-growing broilers. It mainly occurs in broilers aged 4-7 weeks that grow rapidly in winter and spring. Clinically, broilers will become ill after 28 days of growth due to hypoxia caused by various reasons, and the mortality rate will increase before they are marketed. In recent years, the incidence of the disease has been on the rise. Epidemiological reports of the disease have been reported in more than a dozen provinces and cities in my country. Every year, about 7 billion broilers worldwide are harmed by ascites syndrome, causing economic losses of up to tens of billions of dollars. Therefore, the development of effective drug research and development for the prevention and treatment of BAS has become a global problem that needs to be solved urgently.
[0003] my country is a multi-ethnic country with a long history. It has formed a unique natural medicine application system in thousands of years of development. Tibetan medicine is an important ethnic resource in my country, with extremely high medicinal research value. It is mainly produced in the Qinghai-Tibet Plateau and Tibetan settlements in my country. It has a rich variety and is another treasure trove of Chinese medicinal resources. Representative medicines include saffron, hairy terminalia, terminalia, etc.
[0004] Saffron is the dried stigma of Crocus sativus L., a plant of the Iridaceae family. It is also known as saffron. It is sweet in taste, slightly cold in nature, and enters the heart and liver meridians. It has the effects of promoting blood circulation and removing blood stasis, clearing away heat and detoxifying, promoting diuresis and removing dampness, relieving depression and calming the mind, and has strong physiological activity. Studies have shown that saffron can reduce the increase in blood pressure and the thickness of the aorta in the middle membrane of hypertensive rats. Crocin is one of the extracts of saffron, which also has the effect of lowering blood pressure and normalizing blood pressure. Crocin has a conjugated polyene structure and has good antioxidant effects. Other in vivo and in vitro studies also show that crocin has antioxidant, anti-inflammatory and vascular protection properties.
[0005] Terminalia chebula is the dried mature fruit of the Terminalia genus of the family Equilibrium, mainly distributed in Tibet and Yunnan, my country. Terminalia chebula tastes sweet and astringent, is neutral in nature, has the effects of clearing away heat and dampness, astringing and nourishing blood, and harmonizing various medicines, and is a common medicinal material for both medicine and food. Studies have shown that the tannin part of Terminalia chebula has a protective effect on high-altitude pulmonary hypertension. The tannin components (Tannin) such as ellagic acid, terminalia tannic acid, and corilagin in Terminalia chebula have multiple pharmacological activities such as anti-inflammatory and antioxidant.
[0006] Traditional Chinese medicine compound screening requires a large number of animal models, with long test cycles, high costs, and difficulty meeting the needs of Chinese medicine mechanism research. With the rapid development of emerging disciplines such as data mining and network pharmacology, big data and basic theoretical support are provided for Chinese veterinary medicine research. Applying data mining and network pharmacology technology to BAS research is conducive to our rapid and accurate discovery of new Chinese medicine compounds and provides new research ideas for disease treatment.
[0007] The invention patent with application number CN113559230A discloses a Chinese medicine composition for preventing and treating broiler ascites syndrome, wherein Chinese medicinal materials such as astragalus, dried ginger, dried orange peel, and Poria cocos are used; the invention patent with application number CN108576473A discloses a chicken feed suitable for preventing and treating broiler ascites syndrome, wherein Chinese medicinal materials such as astragalus, dried orange peel, plantain, and Poria cocos are disclosed. However, there has been no related report on exploring saffron, terminalia chebula, etc., and combining saffron, terminalia chebula, and Chinese medicinal materials in order to treat broiler ascites syndrome. Summary of the invention
[0008] In view of the above-mentioned prior art, the purpose of the present invention is to provide a Chinese medicine composition for treating broiler ascites syndrome. Based on the anti-oxidation, anti-inflammatory, vascular protection, and therapeutic effects on pulmonary hypertension of saffron and Terminalia chebula, the present invention explores the therapeutic effect of Tibetan medicine modified prescription on broiler ascites syndrome, first screens out the basic Chinese medicine formula, and then combines the basic formula with saffron and Terminalia chebula to obtain a Tibetan medicine safflower diuretic prescription for preventing and treating BAS.
[0009] To achieve the above object, the present invention adopts the following technical solution:
[0010] The first aspect of the present invention provides a traditional Chinese medicine composition, which is composed of Poria cocos, dried tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, ginger, saffron, and Terminalia chebula in a weight ratio of (15-20):(10-15):(5-10):(30-35):(15-20):(9-15):(3-9):(9-15).
[0011] Preferably, the traditional Chinese medicine composition is composed of Poria cocos, dried tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, ginger, saffron, and Terminalia chebula in a weight ratio of 15:10:5:30:15:9:3:9.
[0012] The second aspect of the present invention provides a method for preparing the above-mentioned Chinese medicine composition, comprising the following steps:
[0013] Weigh each component according to the weight ratio, then add 8-12 times the weight of water and soak for 10-15 hours, finally decoct twice, each time for 1-2 hours, combine the two decoctions, concentrate and dry to obtain the product.
[0014] Preferably, the decocting temperature is 90-100°C.
[0015] The third aspect of the present invention provides the use of the above-mentioned Chinese medicine composition in the preparation of a medicine for treating chicken ascites syndrome.
[0016] The fourth aspect of the present invention provides a medicine for treating chicken ascites syndrome, which uses the above-mentioned Chinese medicine composition as an active ingredient.
[0017] Preferably, the drug further comprises a pharmaceutically acceptable excipient.
[0018] Preferably, the auxiliary material includes one or more of starch, dextrin and citric acid.
[0019] Preferably, the drug is in the form of tablets, powders, premixes, granules or oral solutions.
[0020] Beneficial effects of the present invention:
[0021] (1) Based on the antioxidant, anti-inflammatory, vascular protection, and therapeutic effects on pulmonary hypertension of saffron and Terminalia chebula, the present invention explores the therapeutic effect of Tibetan medicine modified prescription on broiler ascites syndrome. The ultimately obtained Chinese medicine composition has reasonable compatibility, is safe and effective, and can treat both the symptoms and the root cause without recurrence.
[0022] (2) The present invention is based on saffron and Terminalia chebula and obtains a Chinese medicine composition that is effective in treating broiler ascites syndrome by screening Chinese medicine compound prescriptions, further exploring the medicinal value of traditional Tibetan medicine in treating poultry and livestock diseases.
[0023] (3) The present invention uses data mining, network pharmacology and other technologies, takes Chinese herbal compound prescriptions and BAS experimental models under big data as research objects, efficiently and accurately screens new Chinese herbal compound prescriptions for the symptomatic treatment of BAS and explores their therapeutic effects, providing information data support and theoretical basis for the rational use of drugs and development of new prescriptions for the clinical treatment of BAS. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1:The distribution map of medicinal properties of effective Chinese medicine prescriptions for the treatment of broiler ascites syndrome;
[0025] Figure 2 :Distribution map of medicinal flavors of effective Chinese medicine prescriptions for the treatment of broiler ascites syndrome;
[0026] Figure 3 :The meridian distribution map of effective prescriptions of Chinese medicine for the treatment of broiler ascites syndrome;
[0027] Figure 4 : Cluster diagram of traditional Chinese medicine variables;
[0028] Figure 5 : Diagram of Chinese medicine composition formula;
[0029] Figure 6 :Venny diagram of active ingredient targets and disease targets of basic Chinese medicine formulas;
[0030] Figure 7 :The “drug-active ingredient-target” network of traditional Chinese medicine basic formula for the treatment of broiler ascites syndrome,
[0031] Among them: the purple part is the Chinese medicine monomer, the round part is the effective ingredient of the Chinese medicine monomer, and the rectangle is the target for treating broiler ascites syndrome;
[0032] Figure 8 : PPI network of potential targets of traditional Chinese medicine formula for the treatment of broiler ascites syndrome;
[0033] Among them: the redder the color, the higher the target ranking and the more important the target;
[0034] Fig. 9 :Key targets of traditional Chinese medicine formula for the treatment of broiler ascites syndrome;
[0035] Fig.10 :GO functional analysis diagram;
[0036] Among them: the green part represents the biological process, the orange part represents the cellular component, and the purple part represents the molecular function;
[0037] Fig.11 : KEGG enrichment analysis diagram;
[0038] Among them: the larger the bubble area, the more enriched genes there are; the redder the bubble color, the more significant the enrichment;
[0039] Fig.12 : Molecular docking diagram;
[0040] Among them: the red part is the small molecule ligand, and the purple part is the macromolecular receptor residue;
[0041] Fig.13 : Molecular docking binding energy;
[0042] Among them: the redder the color, the greater the binding energy and the stronger the docking activity;
[0043] Fig.14 :Broiler autopsy symptom diagram;
[0044] Fig.15 : Morphology of broiler lungs;
[0045] Fig.16 :Comparison of cardiac index of broiler ascites; Different letters indicate significant differences among groups, P<0.05;
[0046] Fig.17 : Broiler lung tissue diagram; red arrows indicate respiratory capillaries; black arrows indicate blood vessel walls, blue arrows indicate edema fluid, green arrows indicate red blood cells, and yellow arrows indicate inflammatory cell infiltration;
[0047] Fig.18 : Comparison of oxidative stress indicators in broiler chickens;
[0048] Among them: (A) is the detection of malondialdehyde (MDA) content in broilers; (B) is the detection of superoxide dismutase (SOD) activity in broilers; (C) is the detection of glutathione peroxidase (GPX) activity in broilers; (D) is the detection of catalase (CAT) activity in broilers; different letters indicate significant differences among groups, P < 0.05;
[0049] Fig.19 :Comparison of NO content in broiler chickens; different letters indicate significant differences among groups, P < 0.05;
[0050] Fig. 20 : Expression level of IL-6 protein in broiler lungs; different letters indicate significant differences among groups, P < 0.05;
[0051] Fig.21 : Comparison of broiler body weight; different letters indicate significant differences among groups, P < 0.05. DETAILED DESCRIPTION
[0052] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0053] As mentioned above, the incidence of broiler ascites syndrome is on the rise. Epidemiological reports of the disease have been found in more than ten provinces and cities in my country. Every year, about seven billion broilers are harmed by ascites syndrome worldwide, causing economic losses of up to tens of billions of dollars. Therefore, the development of effective drugs to prevent and treat BAS has become a global problem that needs to be solved urgently.
[0054] Based on this, the present invention is based on Tibetan medicine saffron and terminalia chebula, and obtains a traditional Chinese medicine composition that can effectively treat broiler ascites syndrome through scientific matching.
[0055] The inventor first consulted the data to learn that saffron can reduce the blood pressure and aortic membrane thickness of hypertensive rats, and that Terminalia chebula also has the effect of protecting plateau pulmonary hypertension. Therefore, the inventor first selected saffron and Terminalia chebula as the components of the Chinese medicine composition. Then, the inventor used "broiler ascites syndrome" and "Chinese medicine compound" as keywords to search and sort out academic journals, degree theses and other documents in the past ten years, screened out 128 Chinese medicine prescriptions, and obtained 164 Chinese medicines; finally, the inventor analyzed the frequency, medicinal properties and medicinal taste of the 164 Chinese medicines, and combined with the methods of association analysis and cluster analysis, according to the principle of "monarch, minister, assistant and messenger", efficiently and accurately screened out the basic Chinese medicine formula for symptomatic treatment of BAS, namely, Poria cocos, tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, ginger, saffron and Terminalia chebula, among which the monarch medicine is Poria cocos and saffron, the minister medicine is tangerine peel and Terminalia chebula, the assistant medicine is Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, and the messenger medicine is ginger.
[0056] In order to enable those skilled in the art to more clearly understand the technical solution of the present application, the technical solution of the present application will be described in detail below in conjunction with specific embodiments.
[0057] The test materials used in the examples of the present invention are all conventional test materials in the art and can be purchased through commercial channels. Experimental methods without detailed conditions are carried out according to conventional test methods or the operating instructions recommended by the supplier.
[0058] The L-arginine used in the present invention was purchased from Shandong Hongxin Bioengineering Co., Ltd., the MDA, SOD, GPX, NO and CAT combination kits were purchased from Jiangsu Biyuntian Company, China, the ELISA combination kit was purchased from Shanghai Jinma Biotechnology Co., Ltd., and the hematoxylin-eosin stain was purchased from Jiangsu Addison Biotechnology Co., Ltd.
[0059] Example 1: Screening of basic components of Chinese medicine compositions.
[0060] 1. Data Mining
[0061] (1) Using keywords such as "broiler ascites syndrome", "Chinese herbal compound", "Ascites Syndrome", and "Plumonary Hypertension syndrome" to search domestic and foreign websites such as CNKI, Wanfang Data Knowledge Service Platform, VIP Chinese Journal Service Platform, Pubmed, NCBI, and Sci-hub, we sorted out academic journals, dissertations, and other documents published from 2010 to 2022, and screened related prescriptions to obtain 128 Chinese herbal prescriptions, which contained 164 Chinese herbal medicines. According to the 2020 edition of the Pharmacopoeia of the People's Republic of China on Veterinary Medicine and Chinese Materia Medica, the names of the 164 Chinese herbal medicines contained in the prescriptions were standardized, and a Chinese herbal compound database was established.
[0062] (2) According to the 2020 edition of the Pharmacopoeia of the People's Republic of China on Veterinary Medicine and the Chinese Materia Medica, the names of 164 Chinese medicines contained in the prescriptions were standardized and a database of Chinese medicine compound prescriptions was established.
[0063] (3) Data analysis
[0064] The frequency of drugs in the 128 prescriptions was statistically analyzed based on Excel tables, and the results are shown in Table 1.
[0065] Table 1 Distribution of effective prescriptions for the treatment of broiler ascites syndrome with a frequency of use greater than 10 for traditional Chinese medicines
[0066]
[0067]
[0068] Then, according to the 2020 edition of the Veterinary Pharmacopoeia of the People's Republic of China, the medicinal properties, taste, meridians and efficacy of each medicine were statistically analyzed, and the association rule analysis and cluster analysis results were performed according to the drug frequency. Figure 1-Figure 3 .
[0069] exist Figure 1-Figure 3 Based on this, we combined the association analysis and cluster analysis methods to obtain the data in Table 2 and Table 3.
[0070] Table 2 Combination pattern of two Chinese medicines in prescription
[0071]
[0072] Table 3 Combination pattern of three Chinese medicines in prescription
[0073]
[0074] The results were analyzed and a new prescription was formulated, which resulted in the basic formula: Poria cocos, dried tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, and ginger.
[0075] 2. Network Pharmacology
[0076] (1) Screening of active drug ingredients
[0077] In the Traditional Chinese Medicine System Pharmacology (TCMSP) and the Encyclopedia of Traditional Chinese Medicine (ETCM), we searched for "Poria cocos", "Chenpi", "Baical Skullcap", "Astragalus", "Plantago", and "Ginger" respectively to obtain their chemical components. Then, we screened them in the TCMSP database with oral bioavailability (OB) ≥ 30% and drug-like property (DL) ≥ 0.18. The components collected in the ETCM database were screened with drug-like property graded as medium and good. After removing duplicate components, we finally obtained the active ingredients that met the conditions. The results are shown in Table 4.
[0078] Table 4 Active ingredients of traditional Chinese medicine in basic formula
[0079]
[0080]
[0081] (2) Collection of active ingredients and disease-related targets
[0082] The active ingredients were unified through the organic small molecule biological activity data (PubChem) database to obtain their Pubchem ID and Smiles (Simplified molecular input line entry system), and Smiles was imported into the SwissTargetPrediction database for target prediction. The human gene database (GeneCard, https: / / www.genecards.org / ) and the human online Mendelian inheritance database (OMIM, http: / / omim.org / ) were searched and summarized with "Ascites Syndrome" and "Broiler Ascites Syndrome" as keywords to collect relevant disease targets.
[0083] (3) Acquisition of potential targets
[0084] The targets of the above active ingredients of the drugs and the targets of the diseases were intersected and visualized using VENNY2.1 to draw a Venn diagram ( Figure 6 ), and obtained 166 potential drug targets for treating diseases.
[0085] (4) Construction of the “drug-active ingredient-potential target” network
[0086] Create Network and Tape files, map out the active ingredients and Chinese medicines corresponding to potential targets, construct a "drug-active ingredient-potential target" network, and import it into Cytoscape 3.9.1 software for visualization, see Figure 7 At the same time, the CytoHubba plug-in was used to analyze its centrality through the MCC algorithm (Maximum Clique Centrality) to obtain the main active ingredients, and finally the main active ingredients of the basic formula of traditional Chinese medicine were obtained, including scutellaria baicalensis flavonoids, scutellaria baicalensis flavonoids, gingerol, epiberberine, baicalein, isocinerin, etc.
[0087] (5) PPI network construction
[0088] Potential targets were imported into the STRING database to construct a protein-protein interaction network. The species was selected as "Gallus gallus", and the minimum interaction score (Combined score) > 0.4 was used as the screening standard. Other parameters were selected as default, and free targets were eliminated. Then the TSV format file was downloaded and imported into Cystscope 3.9.1 for visualization. The results are shown in Figure 8-Figure 9 , and screened out the core targets according to the maximum cluster centrality of the nodes, and obtained the core targets IL-6, STAT3, SRC and BCL2.
[0089] (6) GO enrichment analysis and KEGG pathway enrichment analysis of targets
[0090] The intersection targets of drugs and diseases were imported into the DAVID database and the relevant files were downloaded. The enrichment results were obtained by screening with P < 0.01 and FDR < 0.05, and the results were visualized using the Microbiology Information Online Tool. Figure 10-11 , 68 GO enriched entries and 27 KEGG pathways were obtained, among which the MAPK signaling pathway had the most enriched targets, followed by the FOXO signaling pathway.
[0091] Combined with the analysis of the above core targets, it is predicted that the basic Chinese medicine formula mainly plays a key role in BAS by acting on the three core targets of IL-6, STAT3 and FOXO3a in the FOXO signaling pathway through ingredients such as scutellaria baicalensis flavonoids, gingerol ketones and scutellaria baicalensis flavonoids.
[0092] 3. Molecular docking verification
[0093] In order to verify the accuracy of the core targets screened by network pharmacology, molecular docking was used to verify it. The predicted core targets were selected and the active ingredients in the basic formula were docked (hydrogen bonds were formed between the main active ingredients and the targets, and the binding energy was less than -2kcal·mol-1 (5-Hydroxy-3,7,8,2'-tetramethoxyflavone and FOXO3a were excluded) to obtain the action score. The 3D structure of the active ingredient was downloaded from Pubchem, and the structure of the target protein was from the PDB protein structure database. The protein structure was dehydrated using Pymol to remove other connecting molecules, and then the molecules and targets were docked using Autodock software. Pymol was used to visualize the molecular docking results. The results are shown in Figure 12-13 .
[0094] Figure 12-13 This indicates that there is good binding activity between the predicted core targets and active ingredients, which explains that the basic formula obtained by data mining may play a key role in BAS by acting on the three core targets of IL-6, STAT3 and FOXO3a through the main active ingredients such as scutellaria baicalensis flavonoids, gingerols and baicalein.
[0095] Example 2: Study on prescription ratio
[0096] In order to explore the optimal ratio between drugs, a uniform design experiment was carried out in this example.
[0097] Thirty one-day-old Ross broiler chickens (of either sex) were selected and raised to 14 days of age. They were randomly divided into 6 groups, AF groups, with 5 chickens in each group. The specific groups and drug formulas are shown in Table 5.
[0098] Table 5 Grouping and medication ratio
[0099]
[0100] Based on single factor screening, six factors including Poria cocos, dried tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed and ginger were selected as the test factors for uniform design. Six levels were set for each factor. The 6-factor 6-level U66 uniform design table (Table 6) was used for experimental design. The uniform design experimental grouping was obtained, and the drugs were prepared according to the ratio in Table 5.
[0101] Table 6 Uniform test 6 factors 6 levels table
[0102]
[0103] A 6-factor 6-level U66 uniform design table was used to establish a BAS test model by high-salt drinking water and feeding a high-energy diet. The ascites cardiac index was measured on the 35th day. The method for determining the ascites cardiac index (AHI) of broiler chickens is as follows: dissect the broiler chickens and separate the heart, cut off the left and right atria along the coronary sulcus, and remove excess fat and blood clots. The weight of the whole ventricle is weighed, recorded as TV, and the right ventricle is cut along the anterior and posterior longitudinal grooves, weighed, and recorded as RV. The calculation of the ascites cardiac index is used to determine the occurrence of broiler ascites syndrome. AHI>0.25, and there is ascites in the abdominal cavity, which means that the broiler is judged to have broiler ascites syndrome. Ascites cardiac index (AHI) = right ventricular weight (RV) / whole ventricular weight (TV).
[0104] The optimal compound ratio was analyzed using the quadratic polynomial stepwise regression method, and the results are shown in Tables 7-10.
[0105] Table 7 The therapeutic effects of different proportions of new Chinese herbal medicine compound on broiler ascites syndrome
[0106]
[0107] Table 8 Regression coefficient test of each regression item
[0108]
[0109] Note: P value represents the significance of the test results. P < 0.05 indicates that the result is significant, and P < 0.01 indicates that the result is extremely significant.
[0110] Table 9 Observed values, fitted values and fitting errors of the formula
[0111]
[0112] Table 10 Uniform design test results
[0113]
[0114] Note: Correlation coefficient R = 0.999993; F value = 17176.795208Df = (4, 1), P value = 0.0057, residual standard deviation S = 0.000082, adjusted correlation coefficient Ra = 0.999964
[0115] The results showed that the best therapeutic effect was achieved when the basic formula ratio was Poria: Tangerine Peel: Scutellaria: Astragalus: Plantago: Ginger = 15:10:5:30:15:9.
[0116] On the basis of the basic formula, following the drug dosage range in Part II of the Veterinary Pharmacopoeia of the People's Republic of China (2020 Edition), and in accordance with the compatibility principle of "monarch, minister, assistant and messenger", the ratio of Poria cocos: dried tangerine peel: scutellaria baicalensis: astragalus: plantain seed: ginger: saffron: terminalia chebula was determined to be 15:10:5:30:15:9:3:9, and a Chinese medicine composition capable of treating broiler ascites syndrome was obtained. The formula diagram of the Chinese medicine composition is shown in Figure 5 .
[0117] Example 3: Preparation of Chinese medicine composition.
[0118] Poria cocos, tangerine peel, scutellaria baicalensis, astragalus, plantain seed, ginger, saffron and terminalia chebula are mixed in a weight ratio of 15:10:5:30:15:9:3:9, then 8 times the weight of water is added and soaked for 10 hours, and finally boiled twice at 100°C for 1 hour each time, the two decoctions are combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0119] Example 4: Preparation of Chinese medicine composition.
[0120] Poria cocos, tangerine peel, scutellaria baicalensis, astragalus, plantain seed, ginger, saffron and terminalia chebula are mixed in a weight ratio of 18:12:8:32:18:10:6:12, then 12 times the weight of water is added and soaked for 15 hours, finally boiled twice at 95°C for 2 hours each time, the two decoctions are combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0121] Example 5: Preparation of Chinese medicine composition.
[0122] Poria cocos, tangerine peel, scutellaria baicalensis, astragalus, plantain seed, ginger, saffron and terminalia chebula are mixed in a weight ratio of 20:15:10:35:20:15:9:15, then 10 times the weight of water is added and soaked for 12 hours, finally decocted twice at 100°C, each time for 1.5 hours, the two decoctions are combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0123] Example 6: Preparation of basic formula.
[0124] Poria cocos, tangerine peel, scutellaria baicalensis, astragalus, plantain seed and ginger are mixed in a weight ratio of 15:10:5:30:15:9, then 8 times the weight of water is added and soaked for 10 hours, and finally boiled twice at 100°C for 1 hour each time, the two decoctions are combined, concentrated and dried to obtain a basic Chinese medicine formula.
[0125] Comparative Example 1: Preparation of a Chinese medicine composition.
[0126] Poria cocos and saffron were mixed in a weight ratio of 15:3, then 8 times the weight of water was added and soaked for 10 hours, and finally decocted twice at 100°C, each time for 1 hour, the two decoctions were combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0127] Comparative Example 2: Preparation of a Chinese medicine composition.
[0128] Tangerine peel and Terminalia chebula were mixed in a weight ratio of 10:9, then 8 times the weight of water was added and soaked for 10 hours, and finally decocted twice at 100°C, each time for 1 hour, the two decoctions were combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0129] Comparative Example 3: Preparation of a Chinese medicine composition.
[0130] Scutellaria baicalensis, astragalus, plantain seed and ginger are mixed in a weight ratio of 5:30:15:9, then 8 times the weight of water is added and soaked for 10 hours, and finally decocted twice at 100°C, each time for 1 hour, the two decoctions are combined, concentrated and dried to obtain a traditional Chinese medicine composition.
[0131] Test example 1: Animal test verification.
[0132] 1. Experimental Grouping
[0133] 70 14-day-old Ross broilers with similar body weight were selected for the experiment. A blank group, a model group, a positive control group, and experimental groups 1 to 4 were set up. Ten broilers were randomly assigned to each group for feeding experiments. The grouping and feeding methods were as follows:
[0134] Blank group (control): normal drinking water, basic feed;
[0135] Model group: drinking saline with a sodium ion content of 0.12%, and adding lard and fish oil to the basic feed; the amount of lard added was 3% of the weight of the basic feed, and the amount of fish oil added was 4% of the weight of the basic feed;
[0136] Test group 1 (low): drinking saline with a sodium ion content of 0.12%, adding lard, fish oil and the basic formula prepared in Example 6 to the basic feed, with 1.25 g of the basic formula added to each kg of the basic feed;
[0137] Test group 2 (medium): drinking saline with a sodium ion content of 0.12%, lard, fish oil and the basic formula prepared in Example 6 were added to the basic feed, the lard added was 3% of the weight of the basic feed, the fish oil added was 4% of the weight of the basic feed; 2.5 g of the basic formula was added to each kg of the basic feed;
[0138] Test group 3 (high): drinking salt water with a sodium ion content of 0.12%, lard, fish oil and the basic formula prepared in Example 6 were added to the basic feed, the lard added was 3% of the weight of the basic feed, the fish oil added was 4% of the weight of the basic feed; 5 g of the basic formula was added to each kg of the basic feed;
[0139] Experimental group 4 (medium control): drinking saline with a sodium ion content of 0.12%, adding lard, fish oil and the Chinese medicine composition prepared in Example 3 to the basic feed, the amount of lard added was 3% of the weight of the basic feed, the amount of fish oil added was 4% of the weight of the basic feed; 2.5 g of the Chinese medicine composition was added to each kg of the basic feed;
[0140] Positive control group (L-Arg): Drinking saline with a sodium ion content of 0.12%, lard, fish oil and L-arginine were added to the feed. The amount of lard added was 3% of the weight of the basic feed, the amount of fish oil added was 4% of the weight of the basic feed, and 10g of L-arginine was added to each kg of the basic feed.
[0141] The basic feed was composed of the following ingredients by weight: 15 parts corn, 10 parts bran, 10 parts soybean meal, 5 parts grass meal, 5 parts second meal, 3 parts oil, 3 parts stone powder, 2 parts calcium hydrogen phosphate, 0.5 parts sodium chloride, 0.5 parts lysine, and 0.5 parts methionine.
[0142] 2. Sample Collection
[0143] At 35 days and 42 days, 5 broilers were randomly selected from each group to collect blood and tissue samples. The method was as follows:
[0144] Collection of blood samples: 5 mL of blood was collected from the wing vein, centrifuged at 4°C, 3000 rpm for 10 min, and serum was collected and stored at -80°C for later use.
[0145] Collection of tissue specimens: After blood collection, the broilers were killed by bleeding from the carotid artery, and the heart and lungs were separated and rinsed with pre-cooled PBS. The right ventricle and the whole ventricle were separated and weighed separately. Part of the lung tissue was fixed in 4% paraformaldehyde solution and used to make sections to observe pathological changes.
[0146] Comparison of symptoms between the blank group and the model group during the autopsy process (see Fig.14 ), it can be seen that there is a lot of ascites in the broiler chickens in the model group, while there is no ascites in the blank group, indicating that the experimental modeling is successful.
[0147] Comparison of lung morphology in each group (see Fig.15 ), it can be seen that the lung tissue structure of broilers in the model group was abnormal, the vascular wall was significantly thickened, and inflammatory cells were infiltrated, while the lungs of broilers in the other groups were normal in size and shape.
[0148] 3. Determination of Ascites Cardiac Index (AHI) in Broilers
[0149] After the heart is separated, the left and right atria are cut off along the coronary sulcus, and the excess fat and blood clots are removed. The weight of the whole ventricle is weighed and recorded as TV. The right ventricle is cut off along the anterior and posterior longitudinal grooves and weighed and recorded as RV. The ascites heart index is calculated to determine the occurrence of broiler ascites syndrome. If AHI>0.25 and there is ascites in the abdominal cavity, the broiler is judged to have broiler ascites syndrome.
[0150] Ascites cardiac index (AHI) = right ventricular mass (RV) / total ventricular mass (TV)
[0151] Results Fig.16 ,Combined with anatomical observation, it was found that broilers in the model group suffered from ascites syndrome, while the other experimental groups did not suffer from ascites syndrome.
[0152] 4. HE staining to observe lung morphological changes
[0153] Fresh lung tissue was cut transversely along the left hilum and fixed with 4% paraformaldehyde. According to the conventional paraffin sectioning method, the lung was cut into slices with a thickness of about 4 μm and stained with hematoxylin-eosin to observe the pathological changes of the lung. The results are shown in Fig.17 .
[0154] Depend on Fig.17 It can be seen that the lung tissue in the model group showed structural abnormalities, obvious thickening of the vascular wall, and infiltration of inflammatory cells; compared with the model group, the vascular wall thickness of broiler chickens in the other groups was reduced, and the infiltration of inflammatory cells was alleviated.
[0155] 5. Detection of oxidative stress indicators in broiler chickens
[0156] (1) Remove serum and tissue homogenate supernatant from -80°C and place in a refrigerator at 4°C until the samples are gradually thawed and ready for use.
[0157] (2) Tissue samples were tested according to the instructions of the MDA, SOD, GPX and CAT combination kits.
[0158] Results Fig.18 Compared with the control group, the MDA level in broilers in the model group was significantly increased, and the levels of SOD, CAT and GPX were significantly decreased. Compared with the model group, the MDA level in broilers in the positive control group, the medium-dose control group, and the low-, medium- and high-dose groups was significantly decreased, and the levels of SOD, CAT and GPX were increased, and the effect of the medium-dose group was the most significant.
[0159] 6. Detection of NO content in broilers
[0160] (1) Take out the serum sample from -80℃ and place it in a refrigerator at 4℃ until the sample is gradually thawed and ready for use.
[0161] (2) Serum samples were tested according to the instructions of the NO composition kit.
[0162] Results Fig.19 Compared with the control group, the NO level in the broilers of the model group was significantly increased, while the NO level in the broilers of the other experimental groups was significantly decreased.
[0163] 7. Enzyme-linked immunosorbent assay (ELISA)
[0164] (1) Take out the tissue homogenate supernatant from -80℃ and place it in a refrigerator at 4℃ until the sample is gradually thawed and ready for use.
[0165] (2) Test the tissue sample according to the instructions of the ELISA composition kit.
[0166] Results Fig. 20 Compared with the control group, the expression level of IL-6 protein in broilers in the model group was significantly increased, while the expression level of IL-6 protein in broilers in the other experimental groups was decreased.
[0167] 8. Broiler weight measurement
[0168] Observe and record the health status of broilers. Weigh and record the weight of broilers in groups every 7 days. Then use statistical analysis to analyze the weight of broilers at each stage. The results are shown in Fig.21 It can be seen that the weight of broilers in the model group was significantly lower than that of broilers in other experimental groups.
[0169] From the above experiments, it can be seen that the basic Chinese medicine formula selected by the present invention can effectively treat ascites syndrome in broilers, and the optimal dosage of the basic formula is obtained, that is, 2.5 g / kg. At the same time, based on the data of the above experiments, it can be seen that compared with the basic formula, after adding saffron and Terminalia chebula according to the principle of compatibility of monarch, minister, assistant and envoy, the Chinese medicine composition provided by the present invention has a better effect on the treatment of ascites syndrome in broilers.
[0170] Test Example 2:
[0171] On the basis of Experimental Example 1, the inventors conducted further experiments to verify the relationship between the monarch, minister, adjuvant and envoy of the obtained traditional Chinese medicine composition.
[0172] (1) Test method
[0173] Fifty 14-day-old Ross broiler chickens of similar body weight were randomly divided into 5 groups. The grouping method is as follows:
[0174] Blank group: drinking saline, with lard and fish oil added to feed;
[0175] Experimental group: drinking salt water, with lard, fish oil and the Chinese medicine composition prepared in Example 3 added to the feed;
[0176] Control group 1: drinking salt water, adding lard, fish oil and the Chinese medicine composition prepared in comparative example 1 to the feed;
[0177] Control group 2: drinking salt water, adding lard, fish oil and the Chinese medicine composition prepared in comparative example 2 to the feed;
[0178] Control group 3: Drinking salt water, lard, fish oil and the Chinese medicine composition prepared in comparative example 3 were added to the feed.
[0179] Five broilers were randomly selected from each group at 35 days of age with free access to food and water. Their AHI was calculated using the same method as in Experiment 1. The average value of the results for each group was taken.
[0180] (2) Test results
[0181] Table 11 AHI values of broiler chickens in each group
[0182] Group AHI Blank group 0.28 Experimental Group 1 0.15 Control group 1 0.23 Control group 2 0.24 Control group 3 0.23
[0183] From the above data, it can be seen that the AHI index of the blank group is greater than 0.25, while the AHI of the test group and test group 2 are both less than 0.25, indicating that the Chinese medicine composition provided by the present invention can effectively treat broiler ascites syndrome, and the various components of "monarch, minister, assistant and envoy" have a synergistic effect.
[0184] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A Chinese medicine composition, characterized in that: The Chinese medicine composition is composed of Poria cocos, dried tangerine peel, Scutellaria baicalensis, Astragalus membranaceus, Plantago seed, ginger, saffron and Terminalia chebula in a weight ratio of (15-20):(10-15):(5-10):(30-35):(15-20):(9-15):(3-9):(9-15).
2. The Chinese medicine composition according to claim 1, characterized in that The traditional Chinese medicine composition is composed of tuckahoe, tangerine peel, scutellaria baicalensis, astragalus, plantain seed, ginger, saffron and terminalia chebula in a weight ratio of 15:10:5:30:15:9:3:
9.
3. The method for preparing the Chinese medicine composition according to claim 1, characterized in that: The following steps are involved: Weigh each component according to the weight ratio, then add 8-12 times the weight of water and soak for 10-15 hours, finally decoct twice, each time for 1-2 hours, combine the two decoctions, concentrate and dry to obtain the product.
4. The preparation method according to claim 3, characterized in that: The decoction temperature is 90-100°C.
5. Use of the Chinese medicine composition according to claim 1 in preparing a medicine for treating chicken ascites syndrome.
6. A drug for treating chicken ascites syndrome, characterized in that: The Chinese medicine composition according to claim 1 is used as the active ingredient.
7. The drug for treating chicken ascites syndrome according to claim 6, characterized in that: The drug also includes pharmaceutically acceptable excipients.
8. The drug for treating chicken ascites syndrome according to claim 6, characterized in that: The medicine is in the form of tablets, powders, premixes, granules or oral solutions.
Citation Information
Patent Citations
Compound traditional Chinese medicine for preventing and treating broiler chicken ascites syndrome, and preparation method of decoction of compound traditional Chinese medicine
CN112535701A
